Beryl Drugs Ltd. - Research Center
524606 BERLDRG Group (X) BSE data
Add to watchlist
| Results |
Quarterly
|
| Statement | |
| More |
Quarterly results in brief
(Rs crore)
| Mar' 22 | Dec' 21 | Sep' 21 | Jun' 21 | Mar' 21 | |
|---|---|---|---|---|---|
| Sales | 3.47 | 3.18 | 3.34 | 4.61 | 6.06 |
| Operating profit | -0.34 | 0.21 | -0.13 | 0.67 | 0.63 |
| Interest | 0.10 | 0.12 | 0.11 | 0.11 | 0.14 |
| Gross profit | -0.39 | 0.13 | -0.20 | 0.60 | 0.10 |
| EPS (Rs) | -0.94 | -0.20 | -0.83 | 0.67 | 0.23 |
Quarterly
results in details
| Mar' 22 | Dec' 21 | Sep' 21 | Jun' 21 | Mar' 21 | |
|---|---|---|---|---|---|
| Other income | 0.05 | 0.04 | 0.04 | 0.04 | -0.39 |
| Stock adjustment | -0.40 | 0.01 | 0.13 | -0.04 | 1.08 |
| Raw material | 2.79 | 1.71 | 1.75 | 2.46 | 2.47 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 0.29 | 0.39 | 0.33 | 0.30 | 0.33 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 1.13 | 0.86 | 1.27 | 1.22 | 1.56 |
| Provisions made | - | - | - | - | - |
| Depreciation | 0.27 | 0.27 | 0.24 | 0.30 | 0.24 |
| Taxation | -0.18 | -0.04 | -0.03 | -0.04 | 0.20 |
| Net profit / loss | -0.47 | -0.10 | -0.42 | 0.34 | 0.12 |
| Extra ordinary item | - | - | - | - | 0.45 |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 5.07 | 5.07 | 5.07 | 5.07 | 5.07 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | -9.77 | 6.50 | -3.88 | 14.54 | 10.41 |
| GPM (%) | -10.99 | 4.03 | -6.02 | 12.85 | 1.76 |
| NPM (%) | -13.48 | -3.17 | -12.49 | 7.30 | 2.07 |
© 2022 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis